The current medical treatments for aggressive invasive<unk>  include voriconazole and liposomal amphotericin B in combination with surgical debridement. For the less aggressive allergic bronchopulmonary<unk> , findings suggest the use of oral steroids for a prolonged period of time, preferably for 6–9 months in allergic<unk>  of the lungs. Itraconazole is given with the steroids, as it is considered to have a "steroid-sparing" effect, causing the steroids to be more effective, allowing a lower dose. Other drugs used, such as amphotericin B, caspofungin (in combination therapy only), flucytosine (in combination therapy only), or itraconazole, are used to treat this fungal infection. However, a growing proportion of infections are resistant to the triazoles. A. fumigatus, the most commonly infecting species, is intrinsically resistant to fluconazole.
Aspergillosis
Phaeohyphomycosis
Aspergilloma
Mucormycosis
Histoplasmosis
Tuberculosis
Lobomycosis
Sycosis